$3.60 -0.02 (-0.55%)
11/27/2009 12:59 PM

Bioform Medical (BFRM)

CAPS Rating: 3 out of 5

Results 1 - 6 of 6

Recs

0
Member Avatar EclecticRecluse (75.45) Submitted: 11/10/2009 10:28:05 AM : Outperform Start Price: $3.85 BFRM Score: -6.23

Large Move with Relatively Low Short Interest

Recs

0
Member Avatar FinanceGuy58 (27.55) Submitted: 9/18/2009 8:00:20 PM : Outperform Start Price: $3.55 BFRM Score: -2.07

BFRM offers a facial injectable product to keep aging baby boomer women's wrinkles at bay. The stock was hammered in the economic downturn due to the perception that ladies would cut back discretionary spending...and this was true. It really didn't hurt the top line too badly and as we come out of the recession this stock should really do well.

Recs

0
Member Avatar kurzzz (78.33) Submitted: 10/9/2008 8:32:49 AM : Outperform Start Price: $2.17 BFRM Score: +53.05

Nowhere to go but up

Recs

1
Member Avatar sb101cu (< 20) Submitted: 8/30/2008 11:14:31 PM : Outperform Start Price: $4.17 BFRM Score: -0.56


I have seen a pattern that if a stock has five star CAPS rating AND is near the lower end of the 52 week range, then the stock ALWAYS appreciates by 25 % over the next three months.
I would appreciate if other fools have also noticed this and would correct me if I am wrong

Recs

0
Member Avatar betabata (< 20) Submitted: 3/5/2008 2:38:40 PM : Outperform Start Price: $5.61 BFRM Score: -21.62

wrinkle filler

Recs

0
Member Avatar MD4Beauty (< 20) Submitted: 11/13/2007 5:01:19 PM : Outperform Start Price: $8.40 BFRM Score: -34.07

Bioform markets a dermal filler, Radiesse, which has potential to take market share from Restylane by Medicis. New techniques have been developed which make the injections less painful and easier to perform. The company has priced the product well to compete with other fillers and will be supplying new, thinner (read: less painful) needles with the product in the near future, pending FDA approval.

Results 1 - 6 of 6

Featured Broker Partners